Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BIOPURE CORP | 94,722 | reported | 22 Mar 2006 | tx 17+204,000 |
| VERTEX PHARMACEUTICALS INC / MA | 40,000 | reported | 01 Jun 2010 | tx 76+257,883−100,000 |
| Biodel Inc | 20,000 | reported | 08 Mar 2012 | tx 9+92,874−3,937 |
| CEPHALON INC | 15,000 | reported | 20 May 2010 | tx 6+65,000 |
| BIOCRYST PHARMACEUTICALS INC | 12,971 | reported | 29 Feb 2016 | tx 13+113,304 |
| TRIMERIS INC | 12,500 | reported | 22 Jun 2004 | tx 1+12,500 |
| FISHER SCIENTIFIC INTERNATIONAL INC | 0 | reported | 09 Nov 2006 | tx 8+22,000−42,000 |
| ICAGEN INC | 0 | reported | 02 Sept 2011 | tx 19+249,803−37,157 |
| LIPOSCIENCE INC | 0 | reported | 30 Jan 2013 | tx 2+1,114−2,298 |
| GENENTECH INC | 0 | reported | 26 Mar 2009 | tx 38+85,900−225,800 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 Feb 2016 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 4,396 | 1.99 USD | |
| 30 Nov 2015 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 824 | 10.61 USD | |
| 31 Aug 2015 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 751 | 11.64 USD | |
| 20 May 2015 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 15,000 | 0.00 USD | deriv |
| 02 May 2014 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 15,000 | 0.00 USD | deriv |
| 31 May 2013 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 15,000 | 0.00 USD | deriv |
| 30 Jan 2013 | CONVERSION | LIPOSCIENCE INC | 1,114 | — | |
| 30 Jan 2013 | CONVERSION | LIPOSCIENCE INC | 2,298 | 0.00 USD | deriv |
| 23 May 2012 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 15,000 | 0.00 USD | deriv |
| 13 Mar 2012 | PURCHASE | BIOCRYST PHARMACEUTICALS INC | 2,000 | 5.22 USD | |
| 08 Mar 2012 | GRANT_AWARD | Biodel Inc | 20,000 | 0.00 USD | deriv |
| 30 Sept 2011 | EXERCISE | Biodel Inc | 3,937 | — | |
| 30 Sept 2011 | EXERCISE | Biodel Inc | 3,937 | 0.00 USD | deriv |
| 02 Sept 2011 | TENDER | ICAGEN INC | 25,657 | 6.00 USD | |
| 01 Sept 2011 | EXERCISE | ICAGEN INC | 4,000 | 2.56 USD | |
| 01 Sept 2011 | EXERCISE | ICAGEN INC | 3,750 | 3.36 USD | |
| 01 Sept 2011 | EXERCISE | ICAGEN INC | 3,750 | 4.08 USD | |
| 01 Sept 2011 | EXERCISE | ICAGEN INC | 3,750 | 0.00 USD | deriv |
| 01 Sept 2011 | EXERCISE | ICAGEN INC | 3,750 | 0.00 USD | deriv |
| 01 Sept 2011 | EXERCISE | ICAGEN INC | 4,000 | 0.00 USD | deriv |
| 10 Aug 2011 | PURCHASE | Biodel Inc | 10,000 | 1.16 USD | first after silence |
| 03 Jun 2011 | GRANT_AWARD | ICAGEN INC | 4,000 | 0.00 USD | deriv |
| 12 May 2011 | GRANT_AWARD | BIOCRYST PHARMACEUTICALS INC | 15,000 | 0.00 USD | deriv |
| 01 Oct 2010 | GRANT_AWARD | Biodel Inc | 3,937 | 0.00 USD | deriv |
| 04 Jun 2010 | GRANT_AWARD | ICAGEN INC | 30,000 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 10 Aug 2011.